The Foundation has been invited to attend the Medical College of Wisconsin’s “Updates in Gastrointestinal Oncology” on March 23rd. The program will cover foregut, liver, pancreas, colorectal, and regional approaches to advanced malignancies. The guest faculty will be Dr. Timothy M. Pawlik, Associate Professor of Surgery and Chief of Surgical Oncology from Johns Hopkins. The lectures will review recent abstracts from the ASCO® GI Symposium Meeting in San Francisco earlier this year, and focus on the multidisciplinary advances being made in the field. Ample discussion time has been built into the program as well as case presentations highlighting interventional, radiation and transplant approaches in gastrointestinal cancer.
Exciting things are happening in Washington D.C. in April. CanLiv -The Hepatobiliary Cancer Foundation is holding its 3rd Symposium on April 5th, 2013 and immediately before the beginning of AACR- American Association for Cancer Research Annual Meeting held April 6-10. Further information is included at the link below:
The 3rd Annual “Andrea’s Night” took place on January 12, 2013 and was a huge success. 500 people were in attendance including Harlem Globe trotter Meadow Lark Lemon and retired St Louis Cardinal pitcher Al Hrabarski who both generously donated items to the auction. A total of 31 live auction items, 108 silent auction items and 4 Aching Acres Landscape 10K design and build packages helped to raise $78,000. The Cholangiocarcinoma will be recieving a generous donation of $20,000 while the remaining funds will continue to grow Andrea’s Scholarship fund to the University of Southern Indiana. The Scholarship fund total will be up to $160,545.90 which is one year shy of hitting its goal amount of $200,000. Amazing Work Andrea’s Night and Thank you from the Foundation and all the good work it can continue to provide.
The Cholangiocarcinoma Foundation awarded $184,202 in Grants and Project Funding in 2012. A $40,000 Grant was awarded to the UCSF Hepatobiliary Tissue Bank(CC#124512) which will support the advancing translational Science in Cancers of Biliary Tract through Biorepository of Human Tumor and Blood Specimens. The goal of the HBTB is to advance our understanding of this rare and under-studied tumor type. The immediate goal of the HBTB is to collect high quality frozen cholangiocarcinoma specimens along with paired normal tissue (blood or normal liver) to support the opening of a cholangiocarcinoma cohort with the National Cancer Institute’s the Cancer Genome Atlas (TCGA). Another $40,000 was awarded for Cell Lines and Novel Antibodies at Massachusetts General Hospital. The support will test a novel immunotherapeutic strategy which targets not only differentiated cholangiocarcinoma cells, but all cholangiocarcinoma stem cells. An additional $44,202 was given to the Mayo Clinic for Hepatobiliary Neoplasia Registry and Biorepository. The overall goal is to support the collection of clinical information and samples of blood and tissue from patients with hepatobiliary neoplasia in an IRB approved International Hepatobiliary Neoplasia Registry and Biorepository. Finally, The American Society of Clinical Oncology was awarded $60,000 for its Young Investigator Award. This grant is intended to raise awareness and trigger progress against cholangiocarcinoma, while providing critical early funding for physician-scientists at the beginning of their careers in the field. Providing early career grants helps encourage investigators to focus their career on bile duct cancer.Read More